Successful Construction of a Next-Generation Artificial Skin Model with Blood Vessels Possessing Cellular Diversity - Inventing a New Anti-Aging Care Theory Focused on How Cellular Diversity Creates Skin Elasticity
NQ Score
89/100
N1 Content Completeness
9
AI Summary (NQ-processed)
Rohto Pharmaceutical Co., Ltd., in collaboration with Tokyo Women's Medical University, has successfully developed a next-generation artificial skin model with blood vessels that autonomously reproduces the complex cellular diversity of living skin. This model, which maintains fibroblast and pericyte-like cell populations, demonstrates improved skin barrier function and elasticity. The research also sheds light on how Vitamin C improves signs of aging, paving the way for advanced, animal-free testing for future skincare and pharmaceutical development.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: Who constructed the next-generation artificial skin with blood vessels?
- A: Rohto Pharmaceutical Co., Ltd. and Professor Tatsuya Shimizu of Tokyo Women's Medical University constructed it.
- Q: Which scientific journal published the results of this research?
- A: The research results were published in the online scientific journal EMBO Reports.
- Q: What populations of cells were successfully cultivated in the constructed skin model?
- A: The model successfully cultivated populations of fibroblasts and pericyte-like cells.
- Q: What are the expected applications of this artificial skin achievement?
- A: It is expected to accelerate the development of skincare products and pharmaceuticals.
- Q: What effect of Vitamin C was found in the skin with cellular diversity?
- A: The effects of Vitamin C in improving skin barrier function and elasticity are enhanced.